Improving Company Valuations with Automated Knowledge Discovery,
  Extraction and Fusion
  Performing company valuations within the domain of biotechnology, pharmacy
and medical technology is a challenging task, especially when considering the
unique set of risks biotech start-ups face when entering new markets. Companies
specialized in global valuation services, therefore, combine valuation models
and past experience with heterogeneous metrics and indicators that provide
insights into a company's performance. This paper illustrates how automated
knowledge discovery, extraction and data fusion can be used to (i) obtain
additional indicators that provide insights into the success of a company's
product development efforts, and (ii) support labor-intensive data curation
processes. We apply deep web knowledge acquisition methods to identify and
harvest data on clinical trials that is hidden behind proprietary search
interfaces and integrate the extracted data into the industry partner's company
valuation ontology. In addition, focused Web crawls and shallow semantic
parsing yield information on the company's key personnel and respective contact
data, notifying domain experts of relevant changes that get then incorporated
into the industry partner's company data.
